SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insmed Inc. (INSM)
INSM 189.58-2.5%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: snowflakebeach who wrote (121)1/10/2006 1:40:46 AM
From: snowflakebeach   of 136
 
Mark INCRELEX launch off the Waiting to Hear list.

Tercica Launches Increlex in the U.S.; Only Drug Approved for the Long-Term Treatment of Growth Failure Caused by Severe Primary IGFD

By BusinessWire
Last Update: 1/3/2006 9:00:15 AM Data provided by

BRISBANE, Calif., Jan 03, 2006 (BUSINESS WIRE) -- Tercica, Inc. (TRCA) today announced the U.S. commercial launch of Increlex(TM)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News